Skip to NavigationSkip to content

Pharmafile - Business Services News

Company no longer seeks approval for its oral multi-VEGF receptor inhibitor, citing "outstanding questions raised by the European Medicines...
Mylan CEO Heather Bresch says EpiPen is not profitable, despite the company recording $11 billion in sales
Walmsley replaces Sir Andrew Witty to become most powerful woman in the FTSE100
The agreement was worth more than double the biotech's market value and serves to bolster Allergan's skincare pipeline.
Mylan's Heather Bresch is set to answer questions following the controversy of the company's price increases to its EpiPen
Shingrix showed a 90% efficacy in patients aged 70 and older that was retained over four years compared to MSD's Zostavax
European Commission approves the use of Eisai’s Kisplyx (lenvatinib) for the treatment of renal cell carcinoma
Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches